With Salesforce sinking while the Dow climbs this year, is CRM stock a rare blue-chip bargain or a trap in disguise?

Have you evaluated the performance of Salesforce.com's (CRM) international operations during the quarter that concluded in October 2025? Considering the extensive worldwide presence of this ...

Salesforce ($CRM) announced that the pharmaceutical giant AstraZeneca ($AZN) will deploy Agentforce Life Sciences for ...

Salesforce shows double-digit growth, strong AI momentum, high margins, peer discount, and long-term upside with a $292 target. See why CRM stock is a strong buy.

Second is Salesforce… And boy, I love this quarter. When his (CEO Marc Benioff) company reported last night, it was lights ...

An examination of Salesforce’s (NYSE: CRM) stock price chart reveals a market coiled up like a spring. On the one hand, its ...

We recently compiled a list of the 15 AI News You Should Not Miss. In this article, we are going to take a look at where Salesforce Inc (NYSE:CRM) stands against the other AI stocks. According to a ...

The Salesforce AppExchange Tools Market is primarily driven by the increasing need for seamless CRM customization, advanced workflow automation, and integrated business applications across enterprises ...

Salesforce, Inc. (NYSE:CRM) is one of the stocks to buy according to billionaire Ray Dalio’s Bridgewater Associates. On October 9, Salesforce, Inc. (NYSE:CRM) announced a $1 billion investment to ...

A significant shift is underway in the enterprise software landscape, particularly within the life sciences customer relationship management (CRM) market. Veeva Systems VEEV, a long-time partner of ...

Salesforce’s fair value estimate has been trimmed slightly from about $331 to roughly $327 per share, reflecting a modest reset in expectations as the market reassesses its long term growth path.

Michelle Feinstein details how wealth firms transform CRM systems from basic records into AI-powered hubs that boost ...